Sonim Technologies, Inc. — Q2 2023 Form 10-Q
Entity note: The filing is for Sonim Technologies, Inc. (Nasdaq: SONM), not “DNA X, Inc.” as stated in the request metadata. The quarter ended June 30, 2023; financial amounts below are in U.S. dollars, generally millions unless noted.
Business context and reporting period
Sonim sells rugged mobile phones, tablets and accessories, primarily through wireless carriers, and is expanding into consumer durable devices and connected data products. Its tablet business, launched in 2022, contributed substantially to first-half 2023 revenue. The filing reports Q2 and first-half results against the same 2022 periods.
Financial performance and liquidity
| Metric | Q2 2023 | Q2 2022 | Six months 2023 | Six months 2022 |
|---|---|---|---|---|
| Revenue | $26.8 | $12.0 | $52.6 | $25.2 |
| Gross profit | $4.4 | $2.8 | $8.6 | $4.4 |
| Gross margin | 16.5% | 23.8% | 16.3% | 17.4% |
| Operating income (loss) | $0.7 | $(4.2) | $1.1 | $(11.3) |
| Net income (loss) | $0.5 | $(4.2) | $0.7 | $(11.4) |
| Operating cash flow | Not presented quarterly | Not presented quarterly | $(3.4) | $0.2 |
Cash was $9.7 million at June 30, down from $13.2 million at year-end 2022. Current assets were $43.5 million and current liabilities $30.6 million (approximately 1.42 current ratio). Accounts receivable was $26.6 million, including $1.0 million of vendor non-trade receivables; inventory was $4.7 million. Reported current debt was $74,000 and current lease liability $183,000; no convertible loans or other borrowing structures were in place. Stockholders’ equity was $21.6 million.
First-half operating cash use was attributed principally to a $4.1 million rise in accounts receivable, $1.1 million in capitalized contract fulfillment costs, and payments that reduced accrued severance and bonuses. Cash used in investing was $23,000 and cash used in financing was $73,000.
Material changes versus prior period
- Revenue increased 124% in Q2 and 109% in the first half, mainly from tablet sales ($14.7 million in Q2 and $30.0 million in the first half); tablets were not launched until Q3 2022.
- Smartphone revenue rose to $8.9 million in Q2 from $5.9 million, while feature-phone revenue fell to $3.0 million from $6.0 million.
- Despite higher gross profit dollars, gross margin declined year over year in both periods. Management attributed expected margin improvement to a greater mix of higher-margin smartphones.
- Operating expenses fell 48% in Q2 and 52% for the first half, largely because R&D spending dropped sharply and payroll and outside-consultant costs were reduced. Management said R&D would remain low, with third-party manufacturers expected to fund much of future development and recover costs through product pricing.
- First-half operating cash flow moved from a small source of cash to a $3.4 million use, principally reflecting working-capital needs; 2022 first-half financing included $6.8 million of investor proceeds, versus none in 2023.
Outlook, risks, contingencies and unusual items
Management said existing cash and expected product-sale cash flow should fund obligations for at least one year from issuance of the statements. It expected tablet sales to continue through 2024, smartphone sales to increase in Q3 2023, and new Connected Solutions and consumer durable products to begin launching in 2024. The filing provides no quantified revenue, earnings or cash-flow guidance. Management was investigating debt financing options.
Liquidity is exposed to customer concentration and extended tablet-customer payment terms. One tablet customer represented 78% of trade receivables at June 30; the filing says the company considered the balance collectible. Customer concentration disclosures also show Customer A at 55% of Q2 revenue and 57% for the first half; management separately describes the tablet customer as representing 57% of revenue. Investors should note the different reported percentages and verify customer identities and period-specific exposure.
Noncancelable inventory and component purchase orders totaled approximately $16.3 million at June 30; a third-party software-development commitment was $577,000. Royalty expense was $406,000 for the first half, with per-unit royalties generally below 5% of related net revenue and agreements expiring between 2023 and 2026. The company also disclosed ordinary-course litigation and intellectual-property indemnification obligations; it did not expect other legal matters to materially harm its financial position, results or cash flows. A former CFO’s severance arrangement was approximately $1 million, charged to expense as of the severance date.
Disclosure controls were deemed ineffective due to an ongoing material weakness in IT general controls over financial reporting, including documentation and review of user-role changes. Remediation steps were underway; management expected full remediation by year-end 2023, subject to effective operation and testing. The filing identifies risks from product development and launches, outsourced manufacturing, customer concentration, intellectual-property claims, Nasdaq listing compliance, and entry into data devices. Sonim reported that it regained compliance with Nasdaq’s minimum bid-price requirement in May 2023.
Important facts for investors to verify
- Confirm the issuer identity: this filing is Sonim Technologies, Inc. (SONM), not DNA X, Inc.
- Assess whether the concentrated tablet customer will continue purchasing and paying on extended terms, and reconcile the filing’s customer-revenue concentration percentages.
- Track cash conversion, receivables, working-capital requirements and the company’s ability to fund operations without additional financing.
- Monitor product-launch execution, carrier awards, smartphone/tablet mix and resulting gross margins; the stated 2024 launch outlook is not quantified guidance.
- Check progress in remediating the material weakness and review committed purchase orders and other contractual obligations against available liquidity.